In the dynamic field of pharmaceutical research and development, the availability of high-quality, specialized chemical intermediates is paramount. One such compound making significant contributions is Boc-(R)-3-Amino-4-(2-methyl-phenyl)-butyric Acid, identified by CAS number 269398-80-3. This molecule, often supplied as a white solid or powder, is a key building block for scientists and manufacturers engaged in the synthesis of novel therapeutic agents and advanced peptides.

The structure of Boc-(R)-3-Amino-4-(2-methyl-phenyl)-butyric Acid is particularly noteworthy. It features an amino acid backbone with a chiral center and a protected amine group, specifically the tert-butyloxycarbonyl (Boc) group. This protective group is widely favored in organic synthesis due to its stability under various reaction conditions and its facile removal when needed. The presence of the 2-methylphenyl moiety adds a unique structural element, allowing for the development of compounds with tailored pharmacological properties. Researchers often seek this specific compound when developing treatments for neurological disorders, metabolic diseases, and other conditions where precise molecular architecture is critical for efficacy.

The utility of this intermediate extends across several key areas within the pharmaceutical industry. Firstly, it is a crucial component in the synthesis of Active Pharmaceutical Ingredients (APIs). By incorporating this chiral building block, chemists can construct complex drug molecules with the desired stereochemistry, which is often essential for biological activity and safety. Pharmaceutical manufacturers looking to buy this intermediate for large-scale API production can benefit from sourcing from reputable suppliers who guarantee high purity and lot-to-lot consistency.

Secondly, Boc-(R)-3-Amino-4-(2-methyl-phenyl)-butyric Acid plays a vital role in peptide synthesis. In solid-phase peptide synthesis, protecting groups are indispensable for controlling the stepwise addition of amino acids. The Boc protection on this particular amino acid derivative allows for selective coupling reactions, preventing unwanted side reactions and ensuring the formation of the intended peptide chain. This makes it an attractive raw material for companies specializing in therapeutic peptide manufacturing.

For procurement managers and R&D scientists, identifying a reliable manufacturer and supplier is a priority. Companies that offer Boc-(R)-3-Amino-4-(2-methyl-phenyl)-butyric Acid emphasize not only the product's quality but also the security of its supply chain. Sourcing from a manufacturer in China, for example, can offer competitive pricing and access to a broad range of chemical expertise. When evaluating suppliers, it's important to look for those that provide detailed technical data, certificates of analysis (CoA), and responsive customer service, including quotation assistance.

In conclusion, Boc-(R)-3-Amino-4-(2-methyl-phenyl)-butyric Acid is more than just a chemical compound; it is an enabler of innovation in pharmaceutical science. Its specific structural features and the reliability of its supply chain make it an indispensable tool for drug discovery, API manufacturing, and peptide synthesis. For organizations seeking to purchase this critical intermediate, partnering with established chemical suppliers ensures the quality and consistency needed to drive successful research and development outcomes.